UNSPSC 51442304: Indium in 111 pentetic acid or indium (111in) pentetic acid

This classification denotes a radioconjugate with the molecular formula C14H18N3O10.2H, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5K3UP561AX, a preparation that World Health Organization schedules in its Anatomical Therapeutic Chemical (ATC) Classification.

UNSPSC 51442304 Indium in 111 pentetic acid or indium (111in) pentetic acid is a Commodity code that nominally names a radiopharmaceutical agent used in medical imaging. Recent state and local opportunities posted under this code, however, show a mismatch between the nominal scope and actual procurement activity: the posted solicitations include radiologic equipment and installation services, extended warranties for X-ray machines, maintenance service plans for X-ray inspection systems, and copper sulfate chemicals. None of these purchases align with indium pentetic acid procurement. The issuing bodies span county departments and agencies across different operational contexts—a community college district, a county corrections department, an aviation authority, and a county water or environmental management function—suggesting this code may be incorrectly applied in state and local procurement systems or that the opportunities cited were misclassified.

Geographic activity appears concentrated in Florida and Arizona based on recent postings. Maricopa County issued an IFB (IFB362910) due October 22, 2026 for radiologic equipment and installation at three colleges; Escambia County Correction solicited an extended warranty for X-ray equipment under sole-source procurement (SSCORALM2526005) due August 19, 2026; and Broward County Aviation Department posted an RFI (BLD2132311F1) due July 28, 2026 seeking maintenance services for Rapiscan X-ray inspection systems or documentation of alternate multi-source availability. Pasco County issued an as-needed RFQ (RFQFP261004) due June 26, 2026 for copper sulfate chemicals. The wide variance in commodity types and absence of indium pentetic acid acquisitions suggests this code shows little relevant recent state and local activity for the product it names; pursuit should be informed by direct inquiry with issuing bodies about their actual radiopharmaceutical procurement practices and proper code assignment.